Literature DB >> 24267441

Progress in national and regional guidelines development and deployment for the clinical prevention and control of CVD and diabetes in Africa.

Sruthi Valluri1, Thomas A Gaziano.   

Abstract

Successful efforts to reduce cardiovascular disease in many countries have come as a result of both population based interventions and individually guided interventions. Guidelines serve two purposes directed at the promotion of the individually guided interventions. First, they serve as a method to summarize approved and successful life-style and medical interventions to reduce the burden of cardiovascular disease. Second, they guide health providers on how to identify those at high risk for cardiovascular disease and who might benefit from the available interventions. However, guidelines have been increasingly complex and at times contradictory from one body to another or they may not exist at all in certain countries. This paper will review the current status of guidelines for the region as well as for individual countries. Guidelines for the prevention of CVD as a whole will be evaluated as well as guidelines for individual risk factors such as hypertension, cholesterol, and diabetes. Finally, this paper will address the pitfalls of individual risk factor based guidelines as opposed to the absolute risk approach integrating multiple risk factors into one comprehensive set of guidelines.
© 2013.

Entities:  

Keywords:  CCS; CVD; Cardiovascular disease; Country capacity survey; Diabetes mellitus; Dyslipidemia; EMLs; Essential medicines lists; HTN; Hypertension; LMICs; Low- and middle-income countries; MOH; Ministry of Health; NCDs; Non-communicable diseases; STGs; Standard treatment guidelines; Sub-Saharan Africa; Tobacco; WHO; World Health Organization

Mesh:

Year:  2013        PMID: 24267441      PMCID: PMC3892955          DOI: 10.1016/j.pcad.2013.09.014

Source DB:  PubMed          Journal:  Prog Cardiovasc Dis        ISSN: 0033-0620            Impact factor:   8.194


  12 in total

1.  Ten recommendations to improve use of medicines in developing countries.

Authors:  R Laing; H Hogerzeil; D Ross-Degnan
Journal:  Health Policy Plan       Date:  2001-03       Impact factor: 3.344

Review 2.  Recommendations for prevention, diagnosis and management of hypertension and cardiovascular risk factors in sub-Saharan Africa.

Authors:  Daniel Lemogoum; Yackoob Kassim Seedat; Abdul Fattah Mabadeje; Shanti Mendis; Pascal Bovet; Basden Onwubere; Kathleen Ngu Blackett; Claude Lenfant; Jean René Kabangu; Pierre Block; Mohamed Belhocine; Jean Paul Degaute
Journal:  J Hypertens       Date:  2003-11       Impact factor: 4.844

3.  South African hypertension guideline 2006.

Authors:  Y K Seedat; M A Croasdale; F J Milne; L H Opie; V J Pinkney-Atkinson; B L Rayner; Y Veriava
Journal:  S Afr Med J       Date:  2006-04

Review 4.  Effects of evidence-based clinical practice guidelines on quality of care: a systematic review.

Authors:  M Lugtenberg; J S Burgers; G P Westert
Journal:  Qual Saf Health Care       Date:  2009-10

5.  Adherence to treatment guidelines in primary health care facilities in Botswana.

Authors:  E Boonstra; M Lindbaek; P Khulumani; E Ngome; P Fugelli
Journal:  Trop Med Int Health       Date:  2002-02       Impact factor: 2.622

6.  South African dyslipidaemia guideline consensus statement: 2018 update A joint statement from the South African Heart Association (SA Heart) and the Lipid and Atherosclerosis Society of Southern Africa (LASSA).

Authors:  E Klug; F J Raal; A D Marais; C M Smuts; C Schamroth; D Jankelow; D J Blom; D A Webb
Journal:  S Afr Med J       Date:  2018-10-26

7.  Secular trends in cardiovascular disease risk factors according to body mass index in US adults.

Authors:  Edward W Gregg; Yiling J Cheng; Betsy L Cadwell; Giuseppina Imperatore; Desmond E Williams; Katherine M Flegal; K M Venkat Narayan; David F Williamson
Journal:  JAMA       Date:  2005-04-20       Impact factor: 56.272

8.  Trends in antihypertensive medication use and blood pressure control among United States adults with hypertension: the National Health And Nutrition Examination Survey, 2001 to 2010.

Authors:  Qiuping Gu; Vicki L Burt; Charles F Dillon; Sarah Yoon
Journal:  Circulation       Date:  2012-10-23       Impact factor: 29.690

9.  Explaining the decrease in U.S. deaths from coronary disease, 1980-2000.

Authors:  Earl S Ford; Umed A Ajani; Janet B Croft; Julia A Critchley; Darwin R Labarthe; Thomas E Kottke; Wayne H Giles; Simon Capewell
Journal:  N Engl J Med       Date:  2007-06-07       Impact factor: 91.245

10.  Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010.

Authors:  Rafael Lozano; Mohsen Naghavi; Kyle Foreman; Stephen Lim; Kenji Shibuya; Victor Aboyans; Jerry Abraham; Timothy Adair; Rakesh Aggarwal; Stephanie Y Ahn; Miriam Alvarado; H Ross Anderson; Laurie M Anderson; Kathryn G Andrews; Charles Atkinson; Larry M Baddour; Suzanne Barker-Collo; David H Bartels; Michelle L Bell; Emelia J Benjamin; Derrick Bennett; Kavi Bhalla; Boris Bikbov; Aref Bin Abdulhak; Gretchen Birbeck; Fiona Blyth; Ian Bolliger; Soufiane Boufous; Chiara Bucello; Michael Burch; Peter Burney; Jonathan Carapetis; Honglei Chen; David Chou; Sumeet S Chugh; Luc E Coffeng; Steven D Colan; Samantha Colquhoun; K Ellicott Colson; John Condon; Myles D Connor; Leslie T Cooper; Matthew Corriere; Monica Cortinovis; Karen Courville de Vaccaro; William Couser; Benjamin C Cowie; Michael H Criqui; Marita Cross; Kaustubh C Dabhadkar; Nabila Dahodwala; Diego De Leo; Louisa Degenhardt; Allyne Delossantos; Julie Denenberg; Don C Des Jarlais; Samath D Dharmaratne; E Ray Dorsey; Tim Driscoll; Herbert Duber; Beth Ebel; Patricia J Erwin; Patricia Espindola; Majid Ezzati; Valery Feigin; Abraham D Flaxman; Mohammad H Forouzanfar; Francis Gerry R Fowkes; Richard Franklin; Marlene Fransen; Michael K Freeman; Sherine E Gabriel; Emmanuela Gakidou; Flavio Gaspari; Richard F Gillum; Diego Gonzalez-Medina; Yara A Halasa; Diana Haring; James E Harrison; Rasmus Havmoeller; Roderick J Hay; Bruno Hoen; Peter J Hotez; Damian Hoy; Kathryn H Jacobsen; Spencer L James; Rashmi Jasrasaria; Sudha Jayaraman; Nicole Johns; Ganesan Karthikeyan; Nicholas Kassebaum; Andre Keren; Jon-Paul Khoo; Lisa Marie Knowlton; Olive Kobusingye; Adofo Koranteng; Rita Krishnamurthi; Michael Lipnick; Steven E Lipshultz; Summer Lockett Ohno; Jacqueline Mabweijano; Michael F MacIntyre; Leslie Mallinger; Lyn March; Guy B Marks; Robin Marks; Akira Matsumori; Richard Matzopoulos; Bongani M Mayosi; John H McAnulty; Mary M McDermott; John McGrath; George A Mensah; Tony R Merriman; Catherine Michaud; Matthew Miller; Ted R Miller; Charles Mock; Ana Olga Mocumbi; Ali A Mokdad; Andrew Moran; Kim Mulholland; M Nathan Nair; Luigi Naldi; K M Venkat Narayan; Kiumarss Nasseri; Paul Norman; Martin O'Donnell; Saad B Omer; Katrina Ortblad; Richard Osborne; Doruk Ozgediz; Bishnu Pahari; Jeyaraj Durai Pandian; Andrea Panozo Rivero; Rogelio Perez Padilla; Fernando Perez-Ruiz; Norberto Perico; David Phillips; Kelsey Pierce; C Arden Pope; Esteban Porrini; Farshad Pourmalek; Murugesan Raju; Dharani Ranganathan; Jürgen T Rehm; David B Rein; Guiseppe Remuzzi; Frederick P Rivara; Thomas Roberts; Felipe Rodriguez De León; Lisa C Rosenfeld; Lesley Rushton; Ralph L Sacco; Joshua A Salomon; Uchechukwu Sampson; Ella Sanman; David C Schwebel; Maria Segui-Gomez; Donald S Shepard; David Singh; Jessica Singleton; Karen Sliwa; Emma Smith; Andrew Steer; Jennifer A Taylor; Bernadette Thomas; Imad M Tleyjeh; Jeffrey A Towbin; Thomas Truelsen; Eduardo A Undurraga; N Venketasubramanian; Lakshmi Vijayakumar; Theo Vos; Gregory R Wagner; Mengru Wang; Wenzhi Wang; Kerrianne Watt; Martin A Weinstock; Robert Weintraub; James D Wilkinson; Anthony D Woolf; Sarah Wulf; Pon-Hsiu Yeh; Paul Yip; Azadeh Zabetian; Zhi-Jie Zheng; Alan D Lopez; Christopher J L Murray; Mohammad A AlMazroa; Ziad A Memish
Journal:  Lancet       Date:  2012-12-15       Impact factor: 79.321

View more
  5 in total

Review 1.  Medical devices and diagnostics for cardiovascular diseases in low-resource settings.

Authors:  Helen McGuire; Bernhard H Weigl
Journal:  J Cardiovasc Transl Res       Date:  2014-10-08       Impact factor: 4.132

Review 2.  A Latin American perspective on the new ACC/AHA clinical guidelines for managing atherosclerotic cardiovascular disease.

Authors:  Ada Cuevas; Antonio Arteaga; Attilio Rigotti
Journal:  Curr Atheroscler Rep       Date:  2014-04       Impact factor: 5.113

3.  High Blood Pressure in Sub-Saharan Africa: The Urgent Imperative for Prevention and Control.

Authors:  Justin B Echouffo-Tcheugui; Andre P Kengne; Sebhat Erqou; Richard S Cooper
Journal:  J Clin Hypertens (Greenwich)       Date:  2015-07-30       Impact factor: 3.738

4.  PASCAR and WHF Cardiovascular Diseases Scorecard project.

Authors:  Dejuma Yadeta; Wubaye Walelgne; Jean M Fourie; Wihan Scholtz; Oana Scarlatescu; George Nel; Mussie Gebremichael
Journal:  Cardiovasc J Afr       Date:  2021 Jan-Feb       Impact factor: 1.167

5.  Screening for cardiovascular disease risk and subsequent management in low and middle income countries: challenges and opportunities.

Authors:  Pascal Bovet; Arnaud Chiolero; Fred Paccaud; Nick Banatvala
Journal:  Public Health Rev       Date:  2015-11-25
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.